Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

"The government should step in to facilitate lower prices, as has occurred in the rest of the world," writes one reader.

Lexicon Pharmaceuticals Inc. said March 28 it will exclusively license its drug candidate LX9851 to Danish pharmaceutical ...

LONDON, GB / ACCESS Newswire / March 31, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group ...

Swiss National Bank increased its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 34.4% during the 4th ...

American Century Companies Inc. raised its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 55.7% in the fourth quarter, Holdings Channel.com reports. The firm owned ...

Discover how pharmaceutical industry-funded drug trials are creating jobs and driving economic growth in the Buckeye State.

In the assessment of 12-month price targets, analysts unveil insights for Lexicon Pharmaceuticals, presenting an average ...

India's pharmaceutical industry is urging its government to negotiate with Washington from a “position of power” on tariffs ...

FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 ...

The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and ...